Vetericyn Inc., a California-based animal healthcare company, has announced the launch of its new Vetericyn™ equine product, available in a 16-ounce trigger spray for horses.
Vetericyn™ utilizes an FDA-cleared technology that has been used to successfully treat over one million human patients without a single serious adverse effect. Now, the innovative topical wound-care product is available to the animal healthcare market.
Vetericyn™ is the first non-toxic broad-spectrum antimicrobial on the market. The landscape-altering wound and infection control technology works naturally with the animal's immune system to kill bacteria (including staph and drug-resistant MRSA), viruses, fungi and spores without harming healthy tissue.
Read full article at Medical News Today
Thanks to Cindy Mason for suggesting this topic.